Can-Fite BioPharma (CANF) Institutional Ownership $1.54 +0.02 (+1.32%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$1.55 +0.01 (+0.65%) As of 03/27/2025 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Can-Fite BioPharma (NYSE:CANF)CurrentInstitutional OwnershipPercentage21.00%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$408.09KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$16.53K Get CANF Insider Trade Alerts Want to know when executives and insiders are buying or selling Can-Fite BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CANF Institutional Buying and Selling by Quarter Remove Ads Can-Fite BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 BNP Paribas Financial Markets25,185$41K0.0%N/A0.711% 2/14/2025 Two Sigma Securities LLC19,395$32K0.0%-34.4%0.548% 1/30/2025 Rhumbline Advisers26,880$44K0.0%+58.6%0.759% 8/15/2024 Armistice Capital LLC518,853$1.34M0.0%+35.5%14.657% 2/13/2024 Armistice Capital LLC154,363$340K0.0%N/A4.361% 1/17/2024 Schechter Investment Advisors LLC20,077$44K0.0%N/A0.567% 2/10/2022 Acadian Asset Management LLC28,601$36K0.0%-75.1%0.105% 11/16/2021Cetera Advisor Networks LLC130,776$217K0.0%-16.9%0.607% 10/15/2021 Fifth Third Bancorp30,000$50K0.0%N/A0.149% 8/6/2021 StoneX Group Inc.40,000$91K0.0%N/A0.233% 5/21/2021 Citadel Advisors LLC60,077$148K0.0%N/A0.349% 5/19/2021 Virtu Financial LLC46,294$114K0.0%-37.5%0.269% 5/18/2021 Citadel Advisors LLC60,077$148K0.0%N/A0.349% 5/18/2021 Jane Street Group LLC10,665$26K0.0%N/A0.062% 5/14/2021 XTX Topco Ltd11,205$28K0.0%N/A0.065% 5/14/2021 Stifel Financial Corp12,000$30K0.0%N/A0.070% 3/26/2021 Susquehanna International Group LLP15,323$27K0.0%N/A0.090% 2/24/2021 Virtu Financial LLC74,052$132K0.0%+445.7%0.479% 2/10/2021 Renaissance Technologies LLC118,894$212K0.0%+812.7%0.769% (Data available from 1/1/2016 forward)Remove Ads CANF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANF shares? During the previous two years, the following institutional investors and hedge funds held shares of Can-Fite BioPharma shares: Armistice Capital LLC ($1.34M), Rhumbline Advisers ($44K), Schechter Investment Advisors LLC ($44K), and BNP Paribas Financial Markets ($41K), Two Sigma Securities LLC ($32K).Learn more on CANF's institutional investors. What percentage of Can-Fite BioPharma stock is owned by institutional investors? 21.00% of Can-Fite BioPharma stock is owned by institutional investors. Learn more on CANF's institutional investor holdings. Which institutional investors have been buying Can-Fite BioPharma stock? The following institutional investors have purchased Can-Fite BioPharma stock in the last 24 months: Armistice Capital LLC ($290.42K), BNP Paribas Financial Markets ($25.19K), Schechter Investment Advisors LLC ($20.08K), and Rhumbline Advisers ($9.94K). How much institutional buying is happening at Can-Fite BioPharma? Institutional investors have bought a total of 345,615 shares in the last 24 months. This purchase volume represents approximately $791.86K in transactions. Which Can-Fite BioPharma major shareholders have been selling company stock? The following institutional investors have sold Can-Fite BioPharma stock in the last 24 months: Two Sigma Securities LLC ($10.18K). How much institutional selling is happening at Can-Fite BioPharma? Institutional investors have sold a total of 10,175 shares in the last 24 months. This volume of shares sold represents approximately $16.53K in transactions. Related Companies Calidi Biotherapeutics Major Shareholders Allakos Major Shareholders Finch Therapeutics Group Major Shareholders CEL-SCI Major Shareholders Cyclo Therapeutics Major Shareholders Chemomab Therapeutics Major Shareholders Natural Alternatives International Major Shareholders Lisata Therapeutics Major Shareholders NanoViricides Major Shareholders BioVie Major Shareholders This page (NYSE:CANF) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can-Fite BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CANF Stock Free CANF Stock Alerts